Latest filing published 03 Jun 2025 for Neogenomics INC.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Stephen M. Kanovsky: trading record in brief
Stephen M. Kanovsky (board member) discloses dealings in Neogenomics Inc to SEC (Form 4). We count 7 filings; the first trade dates from 6 June 2019 and the latest from 1 June 2025.
The open-market record is one-sided, with 1 purchase worth €28k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants and 2 option exercises. 2025 to date brings 1 purchase and no sales.
Most recently, on 3 June 2025, the filings show an option exercise in Neogenomics Inc. The last purchase on record was published on 9 May 2025, which is 550 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stephen M. Kanovsky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,254 shares0Common StockSEC:0001077183-25-000129:0
- 4,000 shares@ US$7.7811100.0% of flowCommon StockSEC:0001077183-25-000098:0Canonical exit: 5 Aug 2025 (T+90)
- 11,336 shares0Common StockSEC:0001077183-24-000129:0
- 15,556 shares0Common StockSEC:0001077183-22-000112:0
- 3,081 shares0Common StockSEC:0001077183-21-000156:0
5 of 5 declarations
